CD11b has several clinical applications, particularly in diagnostics and therapeutics. It can serve as a biomarker for diagnosing and monitoring inflammatory and autoimmune diseases. Additionally, targeting CD11b with specific inhibitors or antibodies holds therapeutic potential for conditions characterized by excessive inflammation or immune cell activation.
